hNGFwt

Status

Under development - register interest

EMMA IDEM:15774
Citation informationRRID:IMSR_EM:15774 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain namehNGFwt
Alternative namehNGFwt
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolNgfhNGFwt
Gene/Transgene symbolNgf

Information from provider

ProviderSimona Capsoni
Provider affiliationUniversity of Ferrara
Genetic informationWe generated mutant mice harboring the human NGF wild-type gene at the mouse Ngf locus (this strain: hNGFwt, EMMA strain EM:15574) to control for the hNGFR100W/wt strain (EMMA strain EM:15575) which is a model for Hereditary Sensory and Autonomic Neuropathy type V. We cannot guarantee the genotype and the recipient will have to take the responsibility to carry out all the necessary genotypic checks (including sequencing of the PCR products to distinguish wild-type from mutant animals).
Phenotypic informationHomozygous:
Homozygous NGFh/h mice thrive to adulthhod and do not show an alterated pheenotype

Heterozygous:
Homozygous NGFh/m mice thrive to adulthood and do not show an alterated phenotype
Breeding historypCMV6-XL5-human NGF was generated using site-specific mutagenesis PCR. The targeting constructs were generated using classical cloning technologies. Briefly, a BAC (bacterial artificial chromosome; clone RP24-160F12) containing the entire regions of interest flanking the NGF sequence, was used to generate intermediate plasmids by cloning in pBluescript SK(-) the 5 homology arm (from 89489 to 94076, restriction site MfeI) and 3 homology arm (from 94803 to 99710, restriction site HindIII). The human NGF coding sequence was cloned in the pKO2.1 targeting vector carrying the DTA (diptheria toxin A) negative selection cassette. The targeting vector was transfected into R1-p.15 cells (129/Sv background) and positive clones were selected using neomycin resistance and injected into C57BL/6 blastocysts. A “cre-deleter” strain (B6.C-Tg(CMV-cre)1Cgn/J; The Jackson Lab. stock n. 006054), expressing the cre recombinase under the cytomegalovirus (CMV) promoter was used to remove the neomycin selection cassette.
References
  • Cholinergic striatal neurons are increased in HSAN V homozygous mice despite reduced NGF bioavailability.;Testa Giovanna, Calvello Mariantonietta, Cattaneo Antonino, Capsoni Simona, ;2019;Biochemical and biophysical research communications;509;763-766; 30612733
  • The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V.;Testa Giovanna, Mainardi Marco, Morelli Chiara, Olimpico Francesco, Pancrazi Laura, Petrella Carla, Severini Cinzia, Florio Rita, Malerba Francesca, Stefanov Antonia, Strettoi Enrica, Brandi Rossella, Arisi Ivan, Heppenstall Paul, Costa Mario, Capsoni Simona, Cattaneo Antonino, ;2019;The Journal of neuroscience : the official journal of the Society for Neuroscience;39;9702-9715; 31685654
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Literature references

  • Cholinergic striatal neurons are increased in HSAN V homozygous mice despite reduced NGF bioavailability.;Testa Giovanna, Calvello Mariantonietta, Cattaneo Antonino, Capsoni Simona, ;2019;Biochemical and biophysical research communications;509;763-766; 30612733
  • The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V.;Testa Giovanna, Mainardi Marco, Morelli Chiara, Olimpico Francesco, Pancrazi Laura, Petrella Carla, Severini Cinzia, Florio Rita, Malerba Francesca, Stefanov Antonia, Strettoi Enrica, Brandi Rossella, Arisi Ivan, Heppenstall Paul, Costa Mario, Capsoni Simona, Cattaneo Antonino, ;2019;The Journal of neuroscience : the official journal of the Society for Neuroscience;39;9702-9715; 31685654

Information on how we integrate external resources can be found here

Register interest

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).